Direct-to-consumer fertility tests confuse and mislead consumers
Findings from the small, first-of-its-kind ethnographic study reinforce the need for consumer education around the purpose and accuracy of direct-to-consumer hormone-based fertility tests.
Penn Medicine named official health system of the Philadelphia Flyers
The partnership brings two iconic Philadelphia brands together to collaborate on community-driven initiatives.
Losing tongue fat improves sleep apnea
A Penn Medicine study suggests the tongue could be a new target for treating the common sleep disorder.
Living in poor communities, dying from heart disease
A new study, led by Penn Medicine, found counties that experienced the most economic distress from 2010 to 2015 had the highest cardiovascular mortality rates.
Seven years later, PrEP access remains a challenge
Getting PrEP in the hands of high-risk communities remains a challenge; Penn researchers and practitioners are finding ways to reduce barriers and investigate new forms of the drug.
Predicting treatment outcome for leishmaniasis
In a study of patients treated in Brazil, a team led by School of Veterinary Medicine researchers identified genetic factors and features of the infection itself that predict whether patients will respond to treatment.
Tall people: Your hearts are at risk
The research team reveals a strong link between the genetic variants associated with height and one’s risk for arterial fibrillation, and is among the first to demonstrate that height may be a causal—not correlated—risk factor for the condition.
If you’re black and pregnant, heart disease diagnosis may come too late
A Penn study finds black women are diagnosed with peripartum cardiomyopathy significantly later than white women, which likely explains disparities in outcomes.
Kill stomach cancer risk by attacking this common bacteria
Penn researchers are the first to assess Helicobacter pylori infection and gastric cancer risk among certain demographics and ethnic groups.
Complete remission within reach for rare autoimmune disease
The findings may inform use of the recent FDA-approved drug rituximab to better treat patients with pemphigus, a rare chronic autoimmune condition.
In the News
E-Cigarettes Disappoint in a Workplace Quit-Smoking Study
The Perelman School of Medicine’s Scott Halpern led a study on the effects of vaping on smoking cessation. Halpern found that e-cigarettes were no more helpful than other stop-smoking tools, and that “the very best way to help them quit is to offer them money.”
FULL STORY →
New Blood Test for Pregnant Women Could Predict Preterm Birth
The Perelman School of Medicine’s Michal Elovitz discussed the results from her research exploring methods for predicting preterm births. The study’s results were published in Science.
FULL STORY →